Search

Author/Creator Heilmeier, B.

1. PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: AN UPDATE WITH DATA FROM 181 PATIENTS. (12th June 2019)

Authors:
Lammer, F.; May, L.; Martus, P.; Schroers, R.; Schlegel, U.; Hofer, S.; Bairey, O.; Schmitz, N.; Griesinger, F.; Schmidt‐Hieber, M.; Weißinger, F.; Reimer, P.; le Coutre, P.; Fix, P.; Hopfer, O.; Junghanß, C.; Höffkes, H.; Heilmeier, B.; Möhle, R.; Lange, E.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL. (23rd June 2022)

Authors:
Mai, E. K.; Bertsch, U.; Fenk, R.; Tichy, D.; Besemer, B.; Dürig, J.; Schroers, R.; von Metzler, I.; Hänel, M.; Mann, C.; Asemissen, A. M.; Heilmeier, B.; Nievergall, E.; Huhn, S.; Kriegsmann, K.; Weinhold, N.; Luntz, S.; Holderrried, T. A. W.; Trautmann-Grill, K.; Gezer, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
820
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search